Mubadala Investment Co PJSC

Insider Reports History

Entity
Company
Location
P.O. Box 45005, Abu Dhabi, United Arab Emirates
Signature
/s/ Paul David Andrews as attorney-in-fact for Mubadala Investment Company PJSC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mubadala Investment Co PJSC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. 10%+ Owner Class A Common Stock 13M $137M $10.58 Mar 2, 2023 Indirect
Endeavor Group Holdings, Inc. Other* Class A Common Stock 2.23M $55.2M $24.71 Apr 2, 2024 Indirect
Middle Market Apollo Institutional Private Lending 10%+ Owner Common shares of beneficial interest 12.1M May 14, 2024 Indirect

Insider Reports Filed by Mubadala Investment Co PJSC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NONE Middle Market Apollo Institutional Private Lending May 14, 2024 0 $0 3 May 14, 2024 10%+ Owner
EDR Endeavor Group Holdings, Inc. Apr 2, 2024 0 $0 3 Apr 9, 2024 Other*
RXRX RECURSION PHARMACEUTICALS, INC. Mar 2, 2023 1 $522K 4 Mar 3, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Mar 1, 2023 1 $388K 4 Mar 2, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 28, 2023 1 $6.5K 4 Mar 1, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 27, 2023 1 $404K 4 Feb 28, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 24, 2023 1 $834K 4 Feb 27, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 23, 2023 1 $404K 4 Feb 24, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 22, 2023 1 $399K 4 Feb 23, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 21, 2023 1 $731K 4 Feb 22, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 17, 2023 1 $489K 4 Feb 21, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 16, 2023 1 $337K 4 Feb 17, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 14, 2023 1 $50.1K 4 Feb 15, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 13, 2023 1 $259K 4 Feb 14, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 10, 2023 1 $87.8K 4 Feb 13, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Feb 1, 2023 1 $4.78K 4 Feb 2, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Jan 26, 2023 1 $63K 4 Jan 27, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Jan 25, 2023 1 $193K 4 Jan 26, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Dec 23, 2022 11 $7.73M 4 Jan 13, 2023 10%+ Owner
RXRX RECURSION PHARMACEUTICALS, INC. Oct 27, 2022 1 $25M 4 Oct 31, 2022 10%+ Owner